{"retracted":false,"update":{"timestamp":1466985600000,"doi":"10.1039/c6ra90050j","type":"correction"},"doi":"10.1039/c5ra25046c","journal":"RSC Adv.","publisher":"Royal Society of Chemistry (RSC)","title":"Correction: IDO as a drug target for cancer immunotherapy: recent developments in IDO inhibitors discovery"}
